AMRX compared with TEVA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

TEVATeva Pharmaceutical Industries Ltd

Mkt capRevenueRevenue

Compare

AMRXAmneal Pharmaceuticals, Inc.

TEVATeva Pharmaceutical Industries Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMRX 14

—Customer Aunlistedcustomer

—Kashiv Biosciencesunlistedsupplier

—ApiJect Systemsunlistedsupplier

—BIAL-Portela & Caunlistedsupplier

10 more · AMRX chain ›

Shared 0

No shared counterparties.

Only TEVA 8

ALKSAlkermessupplier

URGNUroGen Pharmacustomer

ETONEton Pharmaceuticalscustomer

ANROAlto Neurosciencecustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

4 more · TEVA chain ›

AMRXAmneal Pharmaceuticals, Inc.

20.17▼−1.31%

Mkt cap$6.5BRevenue$796MQ2 FY26Revenue$3.0BFY25

TEVATeva Pharmaceutical Industries Ltd

42.18▲+3.64%

Regular sessionNov 3 '26

Mkt cap$47.4BRevenue$4.1BQ2 FY26Revenue$17.3BFY25

Compare

Regular sessionNov 3 '26

AMRXAmneal Pharmaceuticals, Inc.

TEVATeva Pharmaceutical Industries Ltd

20.17▼−1.31%

Price

42.18▲+3.64%

$6.5B

Mkt cap

$47.4B

Q2 FY26$796M

Revenue

$4.1BQ2 FY26

FY25$3.0B

Revenue

$17.3BFY25

AMRX20.17▼−1.31%vsTEVA42.18▲+3.64%Regular sessionNov 3 '26